SJS Investment Consulting’s Atea Pharmaceuticals AVIR Stock Holding History

SJS Investment Consulting’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19K	Buy	+256	New	+$1.27K	﹤0.01%	1968

Other funds holding AVIR

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return

Certified Advisory Corp Altamonte Springs, Florida $1.24B AUM 21.71% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SJS Investment Consulting's AVIR Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Atea Pharmaceuticals (AVIR) in Q2 2026: 256 shares worth $1.19K. The stake represents ﹤0.01% of the portfolio and ranks #1968 among its holdings.

23 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

SJS Investment Consulting held 256 shares of Atea Pharmaceuticals worth $1.19K as of Q2 2026.
Atea Pharmaceuticals was a new SJS Investment Consulting position in Q2 2026.
Atea Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1968 holding.
23 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.